logo
AI Icon𝛼SK or Search
ENTITY
HUTCHMED

HUTCHMED (HCM US)

56
Analysis
Health Care • Hong Kong
HUTCHMED is an innovative, commercial-stage biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing targeted therapies and immunotherapies for cancer and immunological diseases. The company has several novel oncology products marketed in China, with one also approved in the US, Europe, and Japan. HUTCHMED was founded in 2000 and is headquartered in Hong Kong.
more
Company Event • 05 Mar 2027 08:30 • Upcoming
Add To Calendar

H2 2026

Company Event • 03 Sep 2026 19:30 • Latest

Status update

Company Event • 30 Jul 2026 20:00

H1 2026

Company Event • 28 Apr 2026 22:00

Deutsche Bank ADR Virtual Investor Conference

Company Event • 06 Mar 2026 08:30

H2 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x